CARGO Therapeutics
CRGX
CRGX was delisted on the 18th of August, 2025.
45 hedge funds and large institutions have $809M invested in CARGO Therapeutics in 2023 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
84.88% more ownership
Funds ownership: 0% → 84.88% (+85%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$105M |
| 2 |
RI
RTW Investments
New York
|
+$87.8M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$69.9M |
| 4 |
PA
Perceptive Advisors
New York
|
+$58.3M |
| 5 |
Janus Henderson Group
London,
|
+$45.8M |
Top Sellers
CRGX Hedge Fund Activity: Q4 2023 in Review
45 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in CARGO Therapeutics (CRGX) for Q4 2023, worth a combined $809M.
Buyers outnumbered sellers: 45 funds opened new CRGX positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $105M.
- 45 institutional investors held CARGO Therapeutics (CRGX) as of Q4 2023, up from 0 in Q3 2023.
- Funds reported $809M of CARGO Therapeutics stock for Q4 2023.
- 45 funds opened new CARGO Therapeutics positions in Q4 2023 and 0 closed out, a net change of +45 holders.
- The largest CARGO Therapeutics buyer in Q4 2023 was Fidelity Investments, an estimated $105M added.
Based on aggregated 13F filings for Q4 2023.